Lithuania vs Malta: Cause of death, by non-communicable diseases, ages 0-4, male
Lithuania
51.5%
in 2021
Malta
52.4%
in 2021
Lithuania rank
8th
Malta rank
6th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Lithuania
- Malta
How they compare
Malta currently reports 52.4% against 51.5% in Lithuania, a difference of 0.9%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Lithuania ahead.
Lithuania ranks 8th and Malta ranks 6th of 185 countries.
Across the 3 decades both report, Lithuania averaged higher in 1 and Malta in 2.
Head to head by decade
| Decade | Lithuania | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.9% | 35.5% | 11.4% | Lithuania |
| 2010s | 51.4% | 56.1% | 4.7% | Malta |
| 2020s | 51.6% | 51.8% | 0.2% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Lithuania or Malta?
- Malta, at 52.4% against 51.5% in Lithuania as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Lithuania and Malta?
- 0.9%, with Malta ahead.
- How many years of comparable data are there for Lithuania and Malta?
- 6 years are reported by both, from 2000 to 2021.
- How do Lithuania and Malta rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Lithuania ranks 8th and Malta ranks 6th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.